spacer
spacer

PDBsum entry 1h9v

Go to PDB code: 
protein links
Immune system, membrane protein PDB id
1h9v

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
172 a.a. *
* Residue conservation analysis
PDB id:
1h9v
Name: Immune system, membrane protein
Title: Human fc-gamma-receptor iia (fcgriia), monoclinic
Structure: Low affinity immunoglobulin gamma fc receptor ii-a. Chain: a. Fragment: immunoglobulin g binding domain residue 5-177. Synonym: fc-gamma rii-a, fcrii-a, igg fc receptor ii-a, fc-gamma- riia, cd32, cdw32. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Variant: high responder. Cellular_location: extracellular. Expressed in: escherichia coli. Expression_system_taxid: 469008. Other_details: refolded from inclusion bodies
Biol. unit: Monomer (from PDB file)
Resolution:
3.00Å     R-factor:   not given    
Authors: P.Sondermann,J.Kaiser,U.Jacob
Key ref:
P.Sondermann et al. (2001). Molecular basis for immune complex recognition: a comparison of Fc-receptor structures. J Mol Biol, 309, 737-749. PubMed id: 11397093 DOI: 10.1006/jmbi.2001.4670
Date:
21-Mar-01     Release date:   21-Jun-01    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P12318  (FCG2A_HUMAN) -  Low affinity immunoglobulin gamma Fc region receptor II-a from Homo sapiens
Seq:
Struc:
317 a.a.
172 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 

 
DOI no: 10.1006/jmbi.2001.4670 J Mol Biol 309:737-749 (2001)
PubMed id: 11397093  
 
 
Molecular basis for immune complex recognition: a comparison of Fc-receptor structures.
P.Sondermann, J.Kaiser, U.Jacob.
 
  ABSTRACT  
 
Once antigen is opsonised by IgG it is removed from the circulation by Fcgamma-receptor expressing cells. Fcgamma-receptors are type I transmembrane molecules that carry extracellular parts consisting of two or three immunoglobulin domains. Previously solved structures of Fc-receptors reveal that the N-terminal two Ig-like domains are arranged in a steep angle forming a heart-shaped structure. The crystal structure of the FcgammaRIII/hIgG1-Fc-fragment demonstrated that the Fc-fragment is recognised through loops of the C-terminal receptor domain of the FcgammaRIII. As the overall structure of the FcRs and their Ig ligands are very similar we modelled the Ig complexes with FcgammaRI, FcgammaRII and FcepsilonRIalpha based on the FcgammaRIII/hIgG1-Fc-fragment structure. The obtained models are consistent with the observed biochemical data and may explain the observed specificity and affinities.
 
  Selected figure(s)  
 
Figure 2.
Figure 2. Stereo ribbon representation of the sFcgRIII structure with residues relevant for IgG binding. The amino acid residues of FcgRIII which contact IgG are shown in ball-and-stick representation. Residues contacting the Cg2-A domain are coloured magenta and those contacting the Cg2-B domain green. Potential glycosylation sites are depicted as cyan balls and the disulphide bridges in yellow. The termini are labelled and the b-strands are numbered consecu- tively for the N-terminal domain in black and for the C-terminal domain in blue. The orientation is the same as Figure 1 (upper left), except that it is rotated by approximately 180 ° around the axis perpendicular to the plane of the paper. The Figure was created using MOLSCRIPT 37 and RASTER3D. 38
Figure 5.
Figure 5. Surface analysis of the FcR structures. A surface analysis was performed using the program GRASP 39 with the crystal structures of FcgRIIa, FcgRIIb, FcgRIII and FceRIa as well as the modelled FcgRI. The colour coding spans from hydrophobic (green) to hydrophilic (red) with potential glycosylation sites indicated as blue balls. The viewpoint is indicated with respect to the front view, which shows an identical orientation as in Figure 2. The IgG binding site is surrounded by a black box in the FcgRIII molecule. The unique hydrophobic region on the N-terminal domain of FcgRIII is circled.
 
  The above figures are reprinted by permission from Elsevier: J Mol Biol (2001, 309, 737-749) copyright 2001.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21516097 M.D.Holdom, A.M.Davies, J.E.Nettleship, S.C.Bagby, B.Dhaliwal, E.Girardi, J.Hunt, H.J.Gould, A.J.Beavil, J.M.McDonnell, R.J.Owens, and B.J.Sutton (2011).
Conformational changes in IgE contribute to its uniquely slow dissociation rate from receptor FcɛRI.
  Nat Struct Mol Biol, 18, 571-576.
PDB codes: 2wqr 2y7q
20146709 H.A.Niederer, M.R.Clatworthy, L.C.Willcocks, and K.G.Smith (2010).
FcgammaRIIB, FcgammaRIIIB, and systemic lupus erythematosus.
  Ann N Y Acad Sci, 1183, 69-88.  
20506277 S.T.Jung, T.H.Kang, and G.Georgiou (2010).
Efficient expression and purification of human aglycosylated Fcgamma receptors in Escherichia coli.
  Biotechnol Bioeng, 107, 21-30.  
18957574 S.Bonetto, L.Spadola, A.G.Buchanan, L.Jermutus, and J.Lund (2009).
Identification of cyclic peptides able to mimic the functional epitope of IgG1-Fc for human Fc gammaRI.
  FASEB J, 23, 575-585.  
18667496 F.Bibollet-Ruche, B.A.McKinney, A.Duverger, F.H.Wagner, A.A.Ansari, and O.Kutsch (2008).
The quality of chimpanzee T-cell activation and simian immunodeficiency virus/human immunodeficiency virus susceptibility achieved via antibody-mediated T-cell receptor/CD3 stimulation is a function of the anti-CD3 antibody isotype.
  J Virol, 82, 10271-10278.  
18064051 F.Nimmerjahn, and J.V.Ravetch (2008).
Fcgamma receptors as regulators of immune responses.
  Nat Rev Immunol, 8, 34-47.  
18625238 T.I.Arnon, J.T.Kaiser, A.P.West, R.Olson, R.Diskin, B.C.Viertlboeck, T.W.Göbel, and P.J.Bjorkman (2008).
The crystal structure of CHIR-AB1: a primordial avian classical Fc receptor.
  J Mol Biol, 381, 1012-1024.
PDB code: 2vsd
18363992 X.Y.Liu, L.M.Pop, and E.S.Vitetta (2008).
Engineering therapeutic monoclonal antibodies.
  Immunol Rev, 222, 9.  
17606923 B.C.Viertlboeck, S.Schweinsberg, M.A.Hanczaruk, R.Schmitt, L.Du Pasquier, F.W.Herberg, and T.W.Göbel (2007).
The chicken leukocyte receptor complex encodes a primordial, activating, high-affinity IgY Fc receptor.
  Proc Natl Acad Sci U S A, 104, 11718-11723.  
17446118 M.Lv, Y.Li, M.Yu, Y.Sun, Z.Lin, C.Qiao, Q.Luo, X.Gu, Y.Huang, J.Feng, and B.Shen (2007).
Structured to reduce the mitogenicity of anti-CD3 antibody based on computer-guided molecular design.
  Int J Biochem Cell Biol, 39, 1142-1155.  
17511516 R.S.McIntosh, J.Shi, R.M.Jennings, J.C.Chappel, T.F.de Koning-Ward, T.Smith, J.Green, M.van Egmond, J.H.Leusen, M.Lazarou, J.van de Winkel, T.S.Jones, B.S.Crabb, A.A.Holder, and R.J.Pleass (2007).
The importance of human FcgammaRI in mediating protection to malaria.
  PLoS Pathog, 3, e72.  
16537476 G.A.Lazar, W.Dang, S.Karki, O.Vafa, J.S.Peng, L.Hyun, C.Chan, H.S.Chung, A.Eivazi, S.C.Yoder, J.Vielmetter, D.F.Carmichael, R.J.Hayes, and B.I.Dahiyat (2006).
Engineered antibody Fc variants with enhanced effector function.
  Proc Natl Acad Sci U S A, 103, 4005-4010.  
16888140 Y.Kaneko, F.Nimmerjahn, and J.V.Ravetch (2006).
Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.
  Science, 313, 670-673.  
15937987 A.Verdoliva, D.Marasco, A.De Capua, A.Saporito, P.Bellofiore, V.Manfredi, R.Fattorusso, C.Pedone, and M.Ruvo (2005).
A new ligand for immunoglobulin g subdomains by screening of a synthetic peptide library.
  Chembiochem, 6, 1242-1253.  
16160618 I.Mosyagin, I.Cascorbi, R.Schaub, T.Krüger, and M.Dettling (2005).
Drug-induced agranulocytosis: impact of different fcgamma receptor polymorphisms?
  J Clin Psychopharmacol, 25, 435-440.  
15688344 R.S.Davis, G.R.Ehrhardt, C.M.Leu, M.Hirano, and M.D.Cooper (2005).
An extended family of Fc receptor relatives.
  Eur J Immunol, 35, 674-680.  
15040582 J.M.Woof, and D.R.Burton (2004).
Human antibody-Fc receptor interactions illuminated by crystal structures.
  Nat Rev Immunol, 4, 89-99.  
14610077 P.Maillard, J.P.Lavergne, S.Sibéril, G.Faure, F.Roohvand, S.Petres, J.L.Teillaud, and A.Budkowska (2004).
Fcgamma receptor-like activity of hepatitis C virus core protein.
  J Biol Chem, 279, 2430-2437.  
12757620 B.D.Wines, A.Gavin, M.S.Powell, M.Steinitz, R.R.Buchanan, and P.Mark Hogarth (2003).
Soluble FcgammaRIIa inhibits rheumatoid factor binding to immune complexes.
  Immunology, 109, 246-254.  
12948782 G.A.Lazar, S.A.Marshall, J.J.Plecs, S.L.Mayo, and J.R.Desjarlais (2003).
Designing proteins for therapeutic applications.
  Curr Opin Struct Biol, 13, 513-518.  
12500981 H.J.Gould, B.J.Sutton, A.J.Beavil, R.L.Beavil, N.McCloskey, H.A.Coker, D.Fear, and L.Smurthwaite (2003).
The biology of IGE and the basis of allergic disease.
  Annu Rev Immunol, 21, 579-628.  
14512227 J.R.Desjarlais, and G.A.Lazar (2003).
Negative design for improved therapeutic proteins.
  Trends Biotechnol, 21, 425-427.  
12948783 L.Presta (2003).
Antibody engineering for therapeutics.
  Curr Opin Struct Biol, 13, 519-525.  
12694568 N.M.van Sorge, W.L.van der Pol, and J.G.van de Winkel (2003).
FcgammaR polymorphisms: Implications for function, disease susceptibility and immunotherapy.
  Tissue Antigens, 61, 189-202.  
11891275 F.Facchetti, M.Cella, S.Festa, D.H.Fremont, and M.Colonna (2002).
An unusual Fc receptor-related protein expressed in human centroblasts.
  Proc Natl Acad Sci U S A, 99, 3776-3781.  
12493010 R.S.Davis, G.Dennis, M.R.Odom, A.W.Gibson, R.P.Kimberly, P.D.Burrows, and M.D.Cooper (2002).
Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family.
  Immunol Rev, 190, 123-136.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer